Fertility and Sterility
Volume 92, Issue 2 , Pages 428-433, August 2009

Risk of urinary incontinence symptoms in oral contraceptive users: a national cohort study from the Swedish Twin Register

  • Anastasia Iliadou, Ph.D.

      Affiliations

    • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Ian Milsom, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden
    • ,
  • Nancy L. Pedersen, Ph.D.

      Affiliations

    • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Daniel Altman, M.D., Ph.D.

      Affiliations

    • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
    • Division of Obstetrics and Gynecology, Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
    • Corresponding Author InformationReprint requests to: Daniel Altman, M.D., Ph.D., Department of Medical Epidemiology and Biostatistics, 171 77 Karolinska Institutet, Stockholm, Sweden (FAX: +46-8-622 58 33).

Received 10 June 2008; received in revised form 27 June 2008; accepted 1 July 2008. published online 14 August 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 A.I. has nothing to disclose. I.M. is a consultant for Pfizer and United BioSource, an investigator for Pfizer and Astellas, and a lecturer for Pfizer, Astellas, and Novartis. N.P. has nothing to disclose. D.A. is a consultant for Gynecare and a lecturer for Astellas.

 Supported by a grant from the National Institute of Digestive Disorders and Kidney Diseases (U01 DK066134 to N.P.) and a grant from the Nordic Urogynecological Association.

PII: S0015-0282(08)01413-1

doi:10.1016/j.fertnstert.2008.07.002

Fertility and Sterility
Volume 92, Issue 2 , Pages 428-433, August 2009

Article Tools